on SARTORIUS STED BIO (EPA:DIM)
Sartorius Stedim Biotech: Share Capital and Voting Rights Update
Sartorius Stedim Biotech SA, based in Aubagne, France, issued a declaration regarding its share capital and voting rights as of February 28, 2026. The company reported a total of 97,330,405 shares comprising its issued capital. Additionally, the total number of theoretical voting rights, which includes treasury shares, amounted to 164,793,754. The net voting rights, excluding treasury shares, totalled 164,751,543.
This announcement complies with Article L 233-8-II of the French Commercial Code and Article 223-6 of the general regulations of the AMF. Investors can access the regulatory filing through the EQS News Service, with the document ID 2284046.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SARTORIUS STED BIO news